ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,010.60
      0.00%
      US Tech 100
      16,811.20
      0.35%
      Dow Jones
      38,239.98
      0.00%
      Brent Oil
      85.45
      -1.11%
      Bitcoin
      66,095.31
      -1.14%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. CytomX Therapeutics Inc (CTMX)

      7. CytomX Therapeutics Inc (CTMX) News

      CTMX CytomX Therapeutics Inc

      1.69
      0.02 (1.20%)
      Pre Market
      Last Updated: 08:11:41
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      CytomX Therapeutics Inc CTMX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.02 1.20% 1.69 08:11:41
      Open Price Low Price High Price Close Price Prev Close
      1.67
      more quote information »

      Recent News

      Date Time Source Heading
      4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
      4/08/202408:00GLOBECytomX Therapeutics Announces First Patient Dosed with..
      4/03/202408:00GLOBECytomX Therapeutics Announces Nomination of Second Clinical..
      3/21/202408:00GLOBECytomX Therapeutics Appoints Dr. Zhen Su to Board of..
      3/18/202408:00GLOBECytomX Therapeutics Announces Milestone Achievement in..
      3/11/202416:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
      3/11/202416:10GLOBECytomX Therapeutics Reports 2023 Financial Results and..
      3/11/202416:02EDGAR2Form 8-K - Current report
      3/11/202416:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      3/11/202406:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
      3/04/202408:00GLOBECytomX Therapeutics to Report Fourth Quarter and Full Year..
      2/27/202408:00GLOBECytomX Therapeutics to Present at Upcoming March Investor..
      1/24/202408:00GLOBECytomX Therapeutics Announces FDA Clearance of IND..
      1/19/202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202420:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202420:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/12/202408:00GLOBECytomX Therapeutics to Present at the B. Riley Securities..
      1/04/202408:00GLOBECytomX Therapeutics Outlines 2024 Company Priorities and..
      12/22/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/22/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/22/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/22/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/21/202308:00GLOBECytomX Therapeutics to Present at the 42nd Annual J.P...
      12/19/202319:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/19/202319:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/19/202319:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/19/202319:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/07/202316:15GLOBECytomX Therapeutics Reports Third Quarter 2023 Financial..
      11/07/202316:05EDGAR2Form 8-K - Current report
      11/07/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/01/202308:00GLOBECytomX Therapeutics to Present at Upcoming November Investor..
      10/31/202308:00GLOBECytomX Therapeutics to Report Third Quarter 2023 Financial..
      10/30/202308:00GLOBECytomX Therapeutics to Present Preclinical Data for..
      10/18/202316:30GLOBECytomX Therapeutics Presents Preclinical Profile of..
      9/22/202319:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/22/202319:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/22/202319:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/05/202316:05GLOBECytomX Therapeutics to Present at Upcoming September..
      8/28/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
      8/24/202316:05EDGAR2Form 8-K - Current report
      8/15/202321:40EDGAR2Form S-3 - Registration statement under Securities Act of..
      8/10/202316:05GLOBECytomX Therapeutics to Present at the H.C. Wainwright Immune..
      8/08/202316:15GLOBECytomX Therapeutics Reports Second Quarter 2023 Financial..
      8/08/202316:08EDGAR2Form 8-K - Current report
      8/08/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/01/202308:00GLOBECytomX Therapeutics to Report Second Quarter 2023 Financial..
      7/20/202317:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/20/202317:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
      7/20/202309:00GLOBECytomX Therapeutics Announces New Employment Inducement..

      Your Recent History

      NASDAQ
      CTMX
      CytomX Therapeutics
      Delayed Upgrade Clock